CYTK - Cytokinetics, Incorporated

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5447.41M
Enterprise Value 3287.18M
Trailing P/E N/A
Forward P/E 1-4.59
PEG Ratio (5 yr expected) 1-0.33
Price/Sales (ttm)14.20
Price/Book (mrq)17.05
Enterprise Value/Revenue 39.12
Enterprise Value/EBITDA 6-3.28

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Dec 31, 2018

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-282.26%

Management Effectiveness

Return on Assets (ttm)-21.97%
Return on Equity (ttm)-156.56%

Income Statement

Revenue (ttm)31.5M
Revenue Per Share (ttm)0.58
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)31.5M
EBITDA -87.68M
Net Income Avi to Common (ttm)-106.29M
Diluted EPS (ttm)-1.95
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)198.73M
Total Cash Per Share (mrq)3.62
Total Debt (mrq)42.41M
Total Debt/Equity (mrq)163.54
Current Ratio (mrq)9.36
Book Value Per Share (mrq)0.47

Cash Flow Statement

Operating Cash Flow (ttm)-101.22M
Levered Free Cash Flow (ttm)-75.33M

Trading Information

Stock Price History

Beta (3Y Monthly) 2.03
52-Week Change 310.42%
S&P500 52-Week Change 38.62%
52 Week High 310.44
52 Week Low 35.75
50-Day Moving Average 37.98
200-Day Moving Average 37.42

Share Statistics

Avg Vol (3 month) 3560.39k
Avg Vol (10 day) 3424.9k
Shares Outstanding 555.37M
Float 41.44M
% Held by Insiders 17.32%
% Held by Institutions 175.19%
Shares Short (Mar 29, 2019) 43.03M
Short Ratio (Mar 29, 2019) 44.43
Short % of Float (Mar 29, 2019) 46.67%
Short % of Shares Outstanding (Mar 29, 2019) 45.47%
Shares Short (prior month Feb 28, 2019) 42.58M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 26/1
Last Split Date 3Jun 25, 2013